World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
81
Citations
79275
World Ranking
946
National Ranking
503

Carl Morrison publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Carl Morrison sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 277 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Carl Morrison D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Carl Morrison sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Carl Morrison is affiliated with the Roswell Park Cancer Institute in the United States. Their research is primarily situated within the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Genetics as subfields.

The scientist's work covers key topics including Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Immunotherapy and Immune Responses, CAR-T cell therapy research, Immune Cell Function and Interaction, Renal cell carcinoma treatment, and Angiogenesis and VEGF in Cancer.

Selected recent publications by Carl Morrison include:

  • "T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors," 2021, Nature Communications
  • "Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity," 2020, OncoImmunology
  • "TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer," 2020, Frontiers in Immunology
  • "Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients," 2020, OncoImmunology
  • "Immune profiling and immunotherapeutic targets in pancreatic cancer," 2021, Annals of Translational Medicine

The frequent co-authors associated with their work include Sean T. Glenn, Sarabjot Pabla, Mary Nesline, Jeffrey M. Conroy, and Felicia L. Lenzo.

Publication venues where Carl Morrison has contributed multiple articles include OncoImmunology, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Cancer Research, and Laboratory Investigation.

Best Publications

  • Comprehensive molecular portraits of human breast tumours

    Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt

  • Integrated genomic analyses of ovarian carcinoma

    D. Bell;A. Berchuck;M. Birrer;J. Chien

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Comprehensive genomic characterization of squamous cell lung cancers

    Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt

  • MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.

    Muller Fabbri;Ramiro Garzon;Amelia Cimmino;Amelia Cimmino;Zhongfa Liu

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

    Tao Zuo;Lizhong Wang;Carl Morrison;Xing Chang

  • Norepinephrine Up-regulates the Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinase (MMP)-2, and MMP-9 in Nasopharyngeal Carcinoma Tumor Cells

    Eric V. Yang;Anil K. Sood;Min Chen;Yang Li

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    Weiva Sieh;Martin Köbel;Teri A Longacre;David D Bowtell;David D Bowtell

Frequent Co-Authors

Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Candace S. Johnson
Candace S. Johnson Roswell Park Cancer Institute
Donald L. Trump
Donald L. Trump University of Virginia
Christine B. Ambrosone
Christine B. Ambrosone Roswell Park Cancer Institute
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
James L. Mohler
James L. Mohler Roswell Park Cancer Institute
Gad Getz
Gad Getz Broad Institute
Stephen B. Edge
Stephen B. Edge Roswell Park Cancer Institute
Matthew Meyerson
Matthew Meyerson Harvard University
Eric S. Lander
Eric S. Lander Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring molecular biologists often explore a variety of online degrees that open doors to interdisciplinary careers. For those looking for flexibility and affordability, the best value online interdisciplinary studies degrees prepare students to combine science with other fields, enhancing problem-solving skills across industries.

If you’re interested in understanding scientific progress in context, a masters in history can offer valuable perspectives on the evolution of biomedical discoveries and research ethics, complementing your science background.

Careers that involve information management, such as in research libraries or biotech archives, can benefit from a library science degree. These skills are vital for organizing, accessing, and preserving scientific literature.

Molecular biology graduates may also pivot to clinical or healthcare paths. For instance, becoming a speech-language pathologist is possible through asha approved online speech pathology programs, which meet top professional standards and offer rewarding opportunities in patient care.

Best Scientists Citing Carl Morrison

Trending Scientists

Recently Published Articles